These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 6209193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inosine pranobex and mucocutaneous herpes.
    Lancet; 1985 Jan 26; 1(8422):200-1. PubMed ID: 2578592
    [No Abstract] [Full Text] [Related]

  • 3. [Immunostimulative therapy of herpes zoster (three years' experience with inosiplex) (author's transl)].
    Bunta S, Peris Z.
    Z Hautkr; 1981 Nov 15; 56(22):1457-66. PubMed ID: 6171939
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Isoprinosine therapy of subacute sclerosing panencephalitis].
    Goetz O.
    Monatsschr Kinderheilkd; 1981 Nov 15; 129(11):655-7. PubMed ID: 6172706
    [No Abstract] [Full Text] [Related]

  • 6. An assessment of antiviral drugs for the management of infectious diseases in humans.
    Galasso GJ.
    Antiviral Res; 1981 Jun 15; 1(2):73-96. PubMed ID: 6175275
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ, Cracco J.
    Ann Neurol; 1977 Feb 15; 1(2):183-4. PubMed ID: 70187
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
    Haddad FS, Risk WS.
    Ann Neurol; 1980 Feb 15; 7(2):185-8. PubMed ID: 6154441
    [Abstract] [Full Text] [Related]

  • 12. Inosiplex: an immunomodulation model for the treatment of viral disease.
    Ginsberg T, Glasky AJ.
    Ann N Y Acad Sci; 1977 Mar 04; 284():128-38. PubMed ID: 81634
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immune response in thermally injured guinea-pigs treated with methisoprinol.
    Castelli A, Sbano E, Fimiani M, Francini G, Andreassi L, Gennari C.
    Int J Tissue React; 1984 Mar 04; 6(2):123-6. PubMed ID: 6203860
    [Abstract] [Full Text] [Related]

  • 16. Next on the agenda: drug regulatory reform.
    Bereuter D.
    Nebr Med J; 1981 Feb 04; 66(2):41. PubMed ID: 6168924
    [No Abstract] [Full Text] [Related]

  • 17. [Isoprinosine: therapeutic action and studies in recurrent herpes].
    Nékám K, Török K, Láng I, Gergely P, Petrányi G.
    Orv Hetil; 1980 Jun 08; 121(23):1393-5. PubMed ID: 6160447
    [No Abstract] [Full Text] [Related]

  • 18. SSPE treated with isoprinosine: immunopathological observations.
    Streletz LJ, Sethi BS, Graziani LJ, Duckett SW.
    Ann Neurol; 1985 Jan 08; 17(1):105-6. PubMed ID: 2580477
    [No Abstract] [Full Text] [Related]

  • 19. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E, Rosenbloom L.
    Arch Dis Child; 1980 Oct 08; 55(10):829-30. PubMed ID: 6159826
    [No Abstract] [Full Text] [Related]

  • 20. [The effect of inosiplex in subacute sclerosing panencephalitis (SSPE)].
    Nihei K, Kudo H, Abe T, Naito H, Suzuki S, Miyao M.
    No To Hattatsu; 1984 Jul 08; 16(4):262-70. PubMed ID: 6207848
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.